Anto Biosciences
Anto Biosciences makes the gut microbiome computable so drug developers can predict and optimize individual drug responses. The company builds a multimodal foundation model of microbial communities using multimodal learning, computational modeling, predictive modeling, and data sparsification techniques to link microbiome profiles to drug efficacy. It delivers its technology as a SaaS platform targeting pharmaceutical companies and drug-development teams. The platform supports preclinical and clinical decision-making by integrating diverse microbiome data modalities and scalable computational pipelines.
Anto Biosciences
Anto Biosciences makes the gut microbiome computable so drug developers can predict and optimize individual drug responses. The company builds a multimodal foundation model of microbial communities using multimodal learning, computational modeling, predictive modeling, and data sparsification techniques to link microbiome profiles to drug efficacy. It delivers its technology as a SaaS platform targeting pharmaceutical companies and drug-development teams. The platform supports preclinical and clinical decision-making by integrating diverse microbiome data modalities and scalable computational pipelines.